Ensuring Successful Endpoint Adjudication: Operational Best Practices


October 8, 2026

When people think about endpoint adjudication, they typically picture an independent Endpoint Adjudication Committee (EAC) comprised of experienced physicians reviewing patient cases to determine whether predefined clinical endpoints have been met. That image is certainly accurate — but it only tells part of the story. Much of an EAC’s efficiency and effectiveness is determined before a physician ever opens a case.

Over the years, I have come to believe one of the biggest misconceptions about endpoint adjudication is that its value begins when physicians start reviewing cases. In reality, the value of endpoint adjudication, as determined by quality, consistency, and efficiency, is largely determined by everything that happens before the first case ever reaches the committee.

Independent physician review will always remain the cornerstone of endpoint adjudication. It is designed to reduce potential bias, promote consistency, and strengthen confidence in endpoint classification. But even the most experienced adjudicators can only make decisions based on the information they receive.

 

Successful endpoint adjudication: Where to start

Clinical trials continue to become more complex. Endpoints are increasingly nuanced, therapeutic areas are more specialized, and regulatory expectations continue to evolve.

Successful endpoint adjudication starts with defining clinically meaningful and operationally practical endpoints. It requires a well-written adjudication charter that anticipates challenging scenarios instead of simply documenting governance. Committee members need clear decision criteria, and operational workflows must be designed so every participant understands their role in the adjudication process before the study begins.

 

Preparing the right case packet

One of the most overlooked contributors to a successful endpoint adjudication program is the operational team supporting it. Experienced clinical reviewers play a critical role in preparing cases for physician review. They identify missing documentation, organize source records, verify data completeness, and assemble comprehensive event packages so physicians can focus on clinical decision-making rather than administrative tasks.

One lesson I have learned is that the goal is not simply to prepare a complete case packet — it is to prepare the right case packet. Physicians should receive exactly the information they need to make a confident, well-supported decision, without unnecessary documents that create additional review time or packets that overlook critical evidence. When event packages are thoughtfully assembled, reviewers reach decisions more efficiently, discordance between adjudicators is often reduced, fewer cases require a third adjudicator, and consensus meetings become less frequent. Careful package compilation improves consistency, reduces study costs and shortens timelines.

Consider a cardiovascular outcomes study where several sites submit incomplete hospitalization records. If those deficiencies are identified only after the event reaches the physician committee, the review process quickly becomes a series of clarification requests, follow-up documentation, and repeat reviews. Multiply that across hundreds of suspected events and the impact on timelines becomes significant. When operational teams identify those issues before physician review begins, adjudicators spend their time applying clinical expertise instead of searching for missing information. The result is a more consistent review process, improved committee engagement, and shorter turnaround times without compromising scientific rigor.

In my experience, these are the improvements that sponsors notice most often, even if they never see the work happening behind the scenes.

 

Intuitive electronic adjudication platforms

Electronic adjudication platforms provide secure workflows, audit trails, dashboards, automated notifications, and real-time performance metrics. These tools have made programs easier to manage and have improved visibility into study performance.

Technology should never become another obstacle for busy physicians. Endpoint adjudicators are experts in their therapeutic areas, not necessarily in learning new software. A more user-friendly platform results in a more consistent and timely physician review, query response, and active engagement throughout the study. A simple, intuitive user experience improves compliance, reduces training needs, minimizes support requests, and ultimately saves both time and money for sponsors.

The best technology supports well-designed operational processes. It should simplify good workflows rather than compensate for poor ones.

 

Selecting an effective endpoint adjudication committee

Selecting highly qualified physicians is only part of building an effective EAC.

An effective committee is one whose members work well together. Independent opinions are essential, but so is the ability to respectfully disagree, apply the predefined endpoint criteria, and reach resolution efficiently when opinions differ. Experienced adjudicators understand that not every case will produce unanimous agreement, and well-functioning committees know when to “agree to disagree” and move appropriately to a tiebreaker or consensus process without allowing individual cases to delay the overall study. The balance between scientific discussion and operational discipline keeps adjudication moving while preserving independence and credibility.

 

How to ensure both efficiency and quality

There is sometimes a perception that improving efficiency means asking physicians to review cases more quickly.

I do not believe that’s where meaningful efficiency comes from.

The greatest improvements occur when unnecessary administrative work is removed, workflows are standardized, documentation is complete, and committee members receive exactly what they need the first time. Physicians should spend their time evaluating clinical evidence — not tracking down missing records or resolving avoidable operational issues.

The impact can be measured in practical ways, from case-packet completeness and adjudication turnaround time to discordance, tie-breaker rates, rework, and the frequency of consensus meetings.

When operational excellence supports clinical expertise, efficiency and quality reinforce one another instead of competing.

 

Key takeaways

As endpoint adjudication continues to evolve, sponsors increasingly need partners who understand how operational excellence, clinical expertise, committee dynamics, and fit-for-purpose technology work together as one integrated process.

Independent physician review will always remain at the heart of endpoint adjudication. But the quality of those decisions depends on everything that happens before the first case reaches the committee. In many ways, the unseen work — from preparing the right case packet, to providing intuitive technology, to supporting a collaborative committee — determines the confidence sponsors, regulators, investigators, and ultimately patients can place in the final results. The most effective programs are not necessarily the ones that ask physicians to work faster; they are the ones designed so physicians can spend their time doing what only they can do — evaluate the clinical evidence and make independent clinical judgments.

Contact Us!
Subscribe to our newsletter

Kimberly Warner

Senior Director, Clinical Endpoint Adjudication Services

Kimberly Warner, MS, is Senior Director, Clinical Endpoint Adjudication Services at Axio, a Cytel Company, where she leads the development and delivery of Endpoint Adjudication Committee (EAC) services. She brings more than 20 years of clinical research experience across independent review committees, biometrics, clinical operations, and business strategy in both sponsor and CRO environments.

Kimberly’s career includes roles at Bristol Myers Squibb, PRA Health Sciences, ACI Clinical, and AstraZeneca, supporting global clinical trials across a wide range of therapeutic areas. She believes successful endpoint adjudication goes beyond clinical expertise. It requires clear processes, strong partnerships, and technology that makes it easier for sponsors, sites, and adjudicators to do their jobs effectively.

Kimberly brings a practical, operational approach to clinical research, with a focus on quality, efficiency, and the experience of the people involved. She holds an MS in Statistics and a BA in Economics and Statistics from Rutgers University.

Read full employee bio

Claim your free 30-minute strategy session

Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.

glow-ring
glow-ring-second